Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Phase IIb Trial of Sulindac in Smokers With Bronchial Dysplasia

NCT00368927 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00368927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00368927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Phase IIb Trial of Sulindac in Smokers With Bronchial Dysplasia
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
December 31, 2010
Enrollment
61 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

precancerous condition, stage i non-small cell lung cancer, tobacco use disorder